Intrinsic Value

The intrinsic value of Poltreg SA (PTG) under the Base Case is 8.65 PLN per share. Compared with the current market price of 19.15 PLN, the stock appears Overvalued by 55% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

PTG Intrinsic Value
zł8.65
Overvaluation 55%
Intrinsic Value
Price zł19.15

PTG is cheaper than usual. Still overvalued, but less so than on 92% of days in the past 5 years.

Monitor PTG
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value zł6.92
Get notified when the price drops into your buy zone
Current Price zł19.15
Intrinsic Value zł8.65
Margin of Safety 20% zł6.92
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PTG

Fundamental Analysis

What Poltreg Does

Poltreg SA is a biotechnology company that develops cell-based therapies, with a focus on treatments that use a patient’s own regulatory T cells, or Tregs. Its work centers on making these living-cell medicines for autoimmune and inflammatory diseases, where the immune system attacks healthy tissue. The company does not sell a mass-market drug; it builds and tests highly specialized therapies that are designed to be used in controlled medical settings.

Headquarters
Poland PL
Employees
11
IPO date
Nov 23, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Poltreg SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PTG stock?

The intrinsic value for Poltreg SA (PTG) under the Base Case is 8.65 PLN.

Is PTG stock undervalued or overvalued?

Compared with the current market price of 19.15 PLN, the stock appears Overvalued by 55% .

Back to Top